Pradžia › 1 tipo cukrinis diabetas › New York
1 tipo cukrinis diabetas klinikiniai tyrimai New York
23 tyrimai dėl 1 tipo cukrinis diabetas ieško dalyvių vietose New York.
Miestai New York
Oficialus tyrimo tekstas (anglų kalba)
App-Based Certified Diabetes Education Therapy (AB-CDE)
- Mount Sinai School of Medicine, New York
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT07282639A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- University At Buffalo - Jacobs School Of Medicine- Site Number : 8400006, Buffalo
- Endocrine Associates of West Village- Site Number : 8400064, New York
- Columbia University Irving Medical Center- Site Number : 8400009, New York
Renkami dalyviai3 fazė
Amžius nuo 1 iki 25 · Visoms lytims · Atnaujinta 2026-09-14 · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- UBMD Pediatrics - University of Buffalo, Buffalo
- Hassenfield Children's Hospital, New York
- NYU Langone Diabetes & Endocrine Associates, New York
Renkami dalyviai1/2 fazė
Amžius nuo 12 iki 35 · Visoms lytims · Atnaujinta 2026-09-11 · NCT06783309Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- Columbia University, New York
Renkami dalyviai2 fazė
Amžius nuo 4 iki 34 · Visoms lytims · Atnaujinta 2026-09-09 · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- Columbia University, New York
Renkami dalyviai2 fazė
Amžius nuo 8 iki 45 · Visoms lytims · Atnaujinta 2026-09-08 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- University of Buffalo, Buffalo
Renkami dalyviai1/2 fazė
Amžius nuo 9 iki 20 · Visoms lytims · Atnaujinta 2026-09-02 · NCT07061574Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- SUNY Upstate Medical Center, Albany
Renkami dalyviai
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-08-28 · NCT07599982HLA Demographics Study in Adults With Type 1 Diabetes
- Icahn School of Medicine at Mount Sinai, New York
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-08-28 · NCT06860516Long-Term Outcomes of Teplizumab in Routine Clinical Care
- Investigational Site Number: 8400001, New York
- Investigational Site Number: 8400002, Syosset
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-08-25 · NCT07360080SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- University at Buffalo MD Physicians Group, Buffalo
Renkami dalyviai2 fazė
Amžius nuo 5 iki 40 · Visoms lytims · Atnaujinta 2026-08-24 · NCT07187531APP-MNT: App-Enhanced Medical Nutrition Therapy on Glycemic Outcomes and Quality of Life
- Weill Cornell Medicine, New York
Renkami dalyviai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-19 · NCT07773779A Study of GNTI-122 in Adults Recently Diagnosed With T1D
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University, New York
Renkami dalyviai1 fazė
Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-08-10 · NCT06919354Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- Circuit Clinical, Buffalo
Renkami dalyviaiStebimasis tyrimas
Amžius 2 ir vyresni · Visoms lytims · Atnaujinta 2026-07-01 · NCT06144554Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
- Mount Sinai, New York
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-30 · NCT07676565Kidney Precision Medicine Project
- Mount Sinai, New York
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-14 · NCT04334707Registry for Stage 2 Type 1 Diabetes
- Women & Children's Hospital of Buffalo- Site Number : 8400018, Buffalo
- Feinstein Institute for Medical Research (Northwell)- Site Number : 8400016, Manhasset
- Ten's Medical PC- Site Number : 8400027, Staten Island
- ir dar 1
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-04-13 · NCT06481904Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes
- Montefiore Einstein Medical Center, The Bronx
Renkami dalyviai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-04-01 · NCT06236607Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- SUNY Upstate Medical University, Syracuse
- Albert Einstein College of Medicine / Montefiore Medical Center, The Bronx
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-03-24 · NCT06217302Cholesterol Lowering and Residual Risk in Diabetes, Type 1
- New York VA Hospital, New York
- NYC Health + Hospitals/Bellevue, New York
- NYU Langone Health, New York
- ir dar 1
Renkami dalyviai4 fazė
Amžius nuo 18 iki 89 · Visoms lytims · Atnaujinta 2025-12-29 · NCT05641753Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression
- Albert Einstein College of Medicine, The Bronx
Renkami dalyviai
Amžius nuo 18 iki 64 · Visoms lytims · Atnaujinta 2025-10-30 · NCT05734313TrialNet Pathway to Prevention of T1D
- Columbia University, New York
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 2 iki 45 · Visoms lytims · Atnaujinta 2025-07-01 · NCT00097292NYSCF Scientific Discovery Biobank
- New York Stem Cell Foundation Research Institute, New York
Renkami dalyviaiStebimasis tyrimas
30 Days · Visoms lytims · Atnaujinta 2025-03-03 · NCT06203106PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life
- Mt Sinai, New York
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
0 Days – 99 Years · Visoms lytims · Atnaujinta 2023-11-21 · NCT06141434Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.